Periocular basal cell carcinoma - clinical perspectives

  • Alena Furdova | afrf@mail.t-com.sk Department of Ophthalmology, Faculty of Medicine, Comenius University, Bratislava, Slovakia. https://orcid.org/0000-0001-5689-892X
  • Karolina Kapitanova Department of Ophthalmology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
  • Alexandra Kollarova Department of Ophthalmology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
  • Juraj Sekac Department of Ophthalmology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.

Abstract

Basal cell carcinoma (BCC) as a non-melanoma skin cancer type is the most common malignant tumor throughout the world. The incidence is higher in age over 60. The intense of exposure to ultraviolet radiation is one of the known risk factors. Over 50% of BCC of the periocular region initially occur on the lower lid and inner angle. Literature review of treatment options for basal cell carcinoma, which consist of surgery, or combined techniques plus vismodegib, radiotherapy and imiquimod. The first consideration for treatment of periocular BCC is radical surgical excision using Mohs micrographic technique. Functional and esthetic outcome in patients are important after clear excisions and reconstruction should be carefully considered. Radical exenteration is considered in the case of orbital invasion of high-risk aggressive BCC.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2020-04-30
Info
Issue
Section
Reviews
Keywords:
Periocular tumors, basal cell carcinoma, vismodegib, radiotherapy.
Statistics
  • Abstract views: 222

  • PDF: 75
  • HTML: 0
How to Cite
Furdova, A., Kapitanova, K., Kollarova, A., & Sekac, J. (2020). Periocular basal cell carcinoma - clinical perspectives. Oncology Reviews, 14(1). https://doi.org/10.4081/oncol.2020.420